Tylenol Autism Lawsuit

Tylenol or acetaminophen relieves pain, and it is hard to believe that exposure to everyday over-the-counter medication could cause your child’s autism. Yet, many individual Tylenol autism lawsuit cases have merit, with dozens of studies linking over-the-counter drug use during pregnancy and increased autism diagnoses among offspring.

The personal injury attorneys at Rosenfeld Injury Lawyers, LLC, advocate for victims injured by prenatal exposure to Tylenol or generic acetaminophen in Tylenol autism cases.

Call our dangerous drug lawyers today at (888) 424-5757 (toll-free) or use the contact form to schedule a free consultation regarding a Tylenol autism class action lawsuit.

We specialize in Tylenol/acetaminophen lawsuits involving autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), and neurodevelopmental disorders.

Recent scientific research on the cord blood samples of children whose mothers took Tylenol (acetaminophen) while pregnant linked drug use and autism/developmental disorders.

The fetal exposure to Tylenol/acetaminophen cord blood samples contained high levels of the drug pregnant women took for pain relief.

A Johns Hopkins University study found antenatal exposure to acetaminophen led to adverse neurodevelopmental outcomes, including developmental disorders like ASD.

Taking Tylenol or Acetaminophen Products

Acetaminophen is a pain reliever and fever reduction medication found in many over-the-counter medicines, making Tylenol reasonably common. Prenatal acetaminophen usage has led to pregnancy complications.

The research linking pregnant women taking acetaminophen-based products has led to a rise in Tylenol autism lawsuits.

Children Taking Tylenol or Generic Acetaminophen

One fetal brain development study found that children who took acetaminophen during their first year of life were more likely to develop autism spectrum disorder.

Another Johns Hopkins University study found that children who took Tylenol six times or more in their first year had an increased risk (three times more likely) of developing ASD and complex developmental disorders.

While these studies do not prove that acetaminophen causes ASD, Complex Developmental Disorder, or ADHD (attention deficit hyperactivity disorder), they suggest that there may be a link between the two.

If you are concerned about antenatal exposure to Tylenol, and your child’s development, contact our dangerous drug lawyers at (888) 424-5757 for a free legal consultation regarding Tylenol autism lawsuits.

Tylenol class action lawsuit cases have been consolidated into multidistrict litigation (MDL) in the US District Court for the Southern District of New York.

What Is Tylenol (Generic Acetaminophen)?

Tylenol, or generic acetaminophen, is an effective pain reliever and fever reducer. The over-the-counter medicine is a nonsteroidal anti-inflammatory drug (NSAID).

Acetaminophen relieves pain such as headaches, muscle aches, toothaches, menstrual cramps, arthritis, or other types of pain. It also reduces fever symptoms in people with chickenpox or the flu.

Expectant mothers have been told to avoid taking acetaminophen, also known as Tylenol, during their pregnancy to ensure nothing influences fetal brain development.

Previous acetaminophen medical records research found significant health risks, suggesting a link between Tylenol usage (prolonged exposure or not) and an increased possibility of neurological disorders in children.

What Is Autism Spectrum Disorder (ASD)?

ASD affects how a person communicates and relates to others. It can also impact how a person sees the world and their behavior. Autism is estimated to occur in one in eighty-eight children in the United States, according to the Centers for Disease Control and Prevention (CDC).

Boys are four times more likely to have autism than girls. While the cause of autism is unknown, scientific research conducted by Johns Hopkins Medicine and others suggests a combination of genetics and environmental factors may cause it.

One of the common symptoms of someone diagnosed with autism that is often misunderstood is the child’s seeming lack of interest in socializing with others. Many people see a child with autism as being anti-social or uninterested in other people when it is not always the case.

Children with autism may not understand sarcasm, jokes, or body language, making social interactions challenging. They may be more interested in topics such as numbers, letters, or animals than discussing what happened at school that day.

These behaviors don’t reveal that these children don’t want to socialize; developmental disorders sometimes mean they process social cues differently than neurotypical children.

If you suspect your child’s ASD was influenced by Tylenol exposure, contact our Tylenol autism lawyers today. Let us help you with a Tylenol class action lawsuit.

What Is Attention Deficit Hyperactivity Disorder (ADHD)?

ADHD is characterized by focus, hyperactivity, and impulsiveness problems. It is one of the most common mental disorders in children and adolescents, affecting around 3-5% of children in the United States.

Symptoms can persist into adulthood in some Tylenol autism cases, and adults can have their symptoms subsequently diagnosed as ADHD later in life. ADHD can cause problems at home, school, and in relationships.

There is no definitive cause of ADHD, but it is believed to be caused by environmental and genetic factors.

Focus, Hyperactivity, and Impulsiveness Problems

Typically, symptoms of ADHD appear before age 7 and can cause problems at home, school, and with friends.

There are three primary symptoms of ADHD: problems with focus, hyperactivity, and impulsiveness. Children with ADHD may have trouble paying attention in class, staying seated, or finishing tasks.

They may also be very active and fidgety or have trouble waiting their turn. Children with ADHD are also more likely to act without thinking about the consequences of their actions.

If you think your child may have ADHD, it is crucial to talk to your doctor. There are many treatments available that can help kids manage their symptoms and live successful lives. Treatment for ADHD usually includes behavioral therapy, medication, or a combination.

Correlation Between Antenatal Exposure to Acetaminophen and Autism/ADHD

According to the US Department of Health and Human Services (HHS), much research has been conducted on the correlation between antenatal exposure to acetaminophen, autism, and ADHD.

Some studies suggest a link between the two health risks of antenatal exposure, such as acetaminophen use during pregnancy, while other antenatal exposure studies are inconclusive.

However, in 2021, the scientific journal Nature Reviews Endocrinology published a Consensus Statement from medical experts warning that using Tylenol during pregnancy was unsafe and could lead to higher rates of ADHD diagnosis.

What is known is that more research needs to be conducted to determine if there is scientific evidence that links using acetaminophen during pregnancy and its mental health effects.

Acetaminophen Study

One study published in the journal Pediatrics found that Tylenol/acetaminophen use during pregnancy is more likely to have children diagnosed with ADHD or neurodevelopmental disorders.

The study looked at data from nearly 64,000 children and found that those exposed to acetaminophen prenatally were twice as likely to be diagnosed with ADHD by the time they reached school age.

Another study published in the Journal of the American Medical Association (JAMA) Pediatrics found a correlation between prenatal Tylenol exposure and ASD. The study looked at data from nearly 1,500 children and found that those exposed to acetaminophen prenatally were three times more likely to develop   ASD.

Tylenol Usage While Pregnant Raises Concerns

While exposure to acetaminophen during pregnancy studies certainly raises some concerns, it is crucial to remember that they are only correlations – they do not prove that acetaminophen usage causes a neurological disorder or leads to autism or ADHD symptoms.

More research is needed to determine if there is a link between the two and what potential risks might be involved, even with the consensus statement of the Nature Reviews Endocrinology journal.

A Johns Hopkins University study assessed cord blood samples containing acetaminophen levels. The outcomes were astonishing. Children with the highest acetaminophen levels in their cord blood were nearly three times more likely to be diagnosed with autism or ADHD than those with the lowest levels.

If you suspect your child’s autism and ADHD is due to exposure to Tylenol or acetaminophen products in your pregnancy, we can help. Contact our legal team for further information regarding Tylenol lawsuits or how to be included in the Tylenol autism class action MDL.

Exploring the Statistics on Acetaminophen Lawsuits: Tylenol’s Role in Birth Injuries

The landscape of product liability lawsuits related to birth injuries is vast and complex. One intriguing area involves allegations tied to Tylenol, an over-the-counter acetaminophen medication.

Many families have initiated Tylenol lawsuits, claiming that prenatal exposure to the drug caused severe birth injuries.

Acetaminophen Lawsuits: A Growing Trend

Despite being one of the most widely used over-the-counter drugs, acetaminophen has not been free from controversy.

The number of acetaminophen lawsuits has steadily risen in recent years, many of which relate to alleged birth injuries.

These lawsuits claim that manufacturers, including Johnson & Johnson, the maker of Tylenol, failed to adequately warn consumers about potential risks, specifically during pregnancy.

The Tylenol Class Action Lawsuit: A Closer Look

Among the Tylenol class action lawsuit cases, a significant portion specifically focuses on Tylenol.

The most notable is the Tylenol class action lawsuit, representing hundreds of families alleging birth defects related to the drug.

This lawsuit claims that the pharmaceutical giant failed to provide appropriate warnings about the risks of taking Tylenol during pregnancy, leading to unexpected and devastating birth injuries.

Scientific Evidence Supporting Claims

These Tylenol lawsuits are often backed by scientific evidence linking using acetaminophen during pregnancy to birth defects.

Numerous studies have suggested a possible association between prenatal Tylenol exposure and conditions like ADHD, autism, and other developmental disorders.

While the scientific community maintains that more research is needed, this evidence is critical to these product liability civil suits.

The Role of Medical Records in Tylenol Lawsuits

Medical records play a vital role in substantiating these claims.

These records, which detail medication usage during pregnancy, birth outcomes, and subsequent health issues, form the foundation of the Tylenol lawsuit cases.

Accurate, detailed medical records can provide strong evidence of a direct link between Tylenol exposure and birth injuries.

The Magnitude of Product Liability Lawsuits

Product liability civil suits like those targeting Tylenol can extensively impact manufacturers.

They result in substantial financial costs and damage reputation and trust.

For families affected by birth injuries, these lawsuits offer a path toward compensation for the enormous physical, emotional, and financial burdens they endure.

Tylenol Lawsuit Cases

The rising wave of Tylenol lawsuits showcases the importance of thorough safety studies and transparent, clear warnings about potential risks associated with over-the-counter drugs.

As the legal battles continue, they serve as a stark reminder of the duty of pharmaceutical companies to prioritize patient safety above all.

Our Lawyers are Reviewing Tylenol Autism Lawsuits: Filing an Acetaminophen Autism Lawsuit After Autism Diagnosis

Many defendants in Tylenol lawsuits are not drug manufacturers making generic-based drugs, or healthcare professionals prescribing or recommending taking acetaminophen during pregnancy.

Instead, the defending parties in Tylenol autism lawsuits are the retailers that sell generic store brands of acetaminophen, including Osco, Safeway, Walgreens, Walmart, and CVS.

These acetaminophen autism lawsuits seek to hold these companies liable for injuries from taking their Tylenol or acetaminophen products.

Over-the-Counter Tylenol/Acetaminophen During Pregnancy is Unsafe

Tylenol lawsuits for generic brand acetaminophen allege that the retailers knew or should have known about the risks associated with taking acetaminophen during pregnancy and failed to provide warnings.

If you or a loved one has been diagnosed with autism or ADHD after exposure to acetaminophen during pregnancy, you may be entitled to compensation.

Personal injury lawyers are reviewing Tylenol autism lawsuits for families with children with autism or ADHD that may have been caused by exposure to acetaminophen during pregnancy.

If you or a child has been affected by prenatal exposure to the drug, contact a Tylenol autism lawyer today for a free consultation. Filing a Tylenol lawsuit could provide compensation for your damages.

Who Qualifies for Filing a Tylenol Autism Claim?

Attorneys must validate Tylenol autism cases before filing a Tylenol autism ADHD lawsuit should a neurological condition like ADHD or ASD related to acetaminophen or equate brand acetaminophen products exposure during pregnancy be identified in a child.

Getting Information About Tylenol Lawsuits

It is essential to compile evidence to support your Tylenol autism ADHD lawsuit that the fetus was exposed to acetaminophen. It must be established through documented and scientific evidence that Tylenol or a generic equivalent was consumed during pregnancy and that your child subsequently received a neurological condition diagnosis.

Your Rights to Compensation

Long-term Tylenol use during pregnancy may entitle the mother to compensation if her unborn child is subsequently found to have acetaminophen-related autism or other issues. The civil lawsuit might cover compensation, including:

• Medical costs and bills
• Pain and suffering
• Lost income
• Loss of enjoyment of life
• Permanent disability

Proving Liability in Tylenol Autism Lawsuits After Acetaminophen Usage in Pregnant Women

Proving liability from acetaminophen use during pregnancy for pain relief linked to an autism or ADHD diagnosis can be complicated.

However, recent studies have shown a link between acetaminophen use during pregnancy and children’s increased risks of autism.

The research conclusions have led many parents of children with autism to file an individual Tylenol lawsuit against the drug manufacturers and retailers selling the product, seeking compensation for their child’s acetaminophen-related autism.

While it is still early in the product liability autism lawsuit situation, mounting evidence suggests that pregnant women using Tylenol might cause autism.

Given the evidence, there is a strong case for proving liability in a Tylenol autism lawsuit.

Parents whose children have been affected by the condition deserve compensation for their expenses and difficulties.

Proof for a Tylenol Autism Lawsuit

Proving a case that correlates the usage of Tylenol and autism/ADHD might require:

• Acetaminophen medical records indicating that Tylenol/acetaminophen usage during your pregnancy led to your child’s neurological condition diagnosis
• Your child’s psychiatrist or therapist records outlining the treatment used for ADHD symptoms, ASD symptoms, or other neurological disorder-related behavioral issues
• All medical notes and transcriptions from healthcare professionals and doctors about your child’s diagnoses related to Tylenol used during your pregnancy, including any exposure to acetaminophen records

Our national product liability lawyers are now reviewing Tylenol autism cases involving children diagnosed with autism whose mothers took the brand name Tylenol or generic brand acetaminophen during their pregnancy.

Our attorneys are basing their acetaminophen autism lawsuits on ADHD/autism diagnoses relating to Tylenol use during pregnancy, neurological/brain disorders, and the company’s failure to advise against using Tylenol while pregnant.

Can I File a Tylenol Autism Lawsuit If I Used Generic Brand Acetaminophen?

Yes, even if you used the generic form of Tylenol, you can still submit a Tylenol autism lawsuit for your child’s ASD (autism spectrum disorder) diagnosis.

The same claim is made in an acetaminophen lawsuit: manufacturers and distributors failed to inform pregnant women of the health dangers of using acetaminophen or Tylenol during pregnancy.

The defendants in a case for generic acetaminophen will change based on the brand used and the location of the drug’s purchase.

Speak to our Tylenol attorneys about compensation in Tylenol autism lawsuits.

Mass Tort Litigation

In a recent move, the Judicial Panel on Multidistrict Litigation (JPML) has created a new mass tort litigation for claims accusing significant retailers such as Costco Wholesale Corp and Walmart Inc. They failed to warn that using acetaminophen, a popular pain, and fever-reduction medication, during pregnancy can cause ASD and ADHD in children.

The claimants allege that companies should have provided explicit warnings about the potential risks of using acetaminophen during pregnancy or early childhood development but failed to do so.

The lawsuit further alleges that Johnson & Johnson and other manufacturers knew or should have known about these risks but took no action to inform the public.

The case is part of a larger conversation surrounding acetaminophen autism cases and whether certain drugs can be linked to developmental disabilities such as ASD or ADHD, as well as how pharmaceutical companies should handle warnings about their products.

While it remains to be seen what the lawsuit’s outcome will be, parents and expectant mothers must discuss any medications they plan to take with their healthcare provider before making any decisions.

The Multidistrict Tylenol Autism Class Action Lawsuit Process

A multidistrict litigation (MDL) Tylenol class action lawsuit is being prepared to incorporate the product liability claims against Tylenol and other acetaminophen manufacturers.

To combine court resources, even if the plaintiffs are spread out across the United States, the court would still hear the Tylenol autism cases in a single jurisdiction. Additionally, it enables plaintiffs to split costs like court fees.

Plaintiffs’ attorneys for the Tylenol autism ADHD lawsuit must persuade a jury that manufacturers, like Johnson & Johnson, violated their duty of care to consumers by failing to alert them to the dangers of acetaminophen/Tylenol use.

To file a Tylenol autism ADHD lawsuit for damages against the manufacturers of acetaminophen or Tylenol medications like Mallinckrodt or Johnson & Johnson, our law firm can help you determine the precise value of your injuries.

June 5, 2023, Plaintiffs Challenge Johnson & Johnson’s Request for Instant Appeal

In a marked shift in legal proceedings, plaintiffs in the Tylenol lawsuit countered Johnson & Johnson’s (J&J) appeal for immediate scrutiny of the court’s preemption and causation rulings.

The plaintiffs formally submitted a motion last week, contending against the company’s request for an urgent appeal.

If you or your family are involved in a Tylenol autism lawsuit or considering initiating one, this development has significant implications.

Here’s why:

If granted, J&J’s pursuit of an immediate appeal would likely put a pause on the ongoing litigation. The proceeding halt could last up to a year, placing all related Tylenol lawsuits in legal limbo.

This delay could add considerable strain and uncertainty for families who have already endured the challenges associated with autism and the ensuing legal battle.

issue of causation

However, the attorneys representing the plaintiffs argue that granting an immediate appeal is not justified in this case. They contend that such urgency is typically reserved for rare exceptions, a criterion they believe does not apply to the current situation.

Further, they assert that the issue of causation – a central element in this lawsuit, which explores whether Tylenol use during pregnancy can lead to autism in children – will soon be addressed.

Daubert Hearing

A Daubert hearing, a legal proceeding specifically designed to assess the admissibility of expert testimony, is scheduled for later this year.

At this hearing, expert opinions on the link between Tylenol and autism will be examined thoroughly, potentially providing a more robust base for the plaintiffs’ case.

Previous Developments in the Tylenol Autism Lawsuits

June 5, 2023: Plaintiff Challenges J&J’s Appeal Request

The plaintiffs objected to Johnson & Johnson’s (J&J) request for an immediate appeal regarding the preemption rulings, potentially affecting the speed of Tylenol autism lawsuits.

May 22, 2023: Dismissal of Texas Case, California Claims Persist

Texas’s “safe harbor” law led to dismissing a Tylenol autism case, while a similar case in California withstood an attempt for dismissal.

May 17, 2023: Retailers Face Lawsuit

Judge Denise L. Cote dismissed arguments by Target Corp. and Walmart Inc. that compliance with federal law absolved them from state law liability for not warning about potential autism or ADHD risks from their acetaminophen products.

May 16, 2023: Plaintiffs in Holding Pattern

Despite six months since the class action MDL consolidation, only 124 cases are pending due to potential plaintiffs awaiting the outcomes of Daubert legal challenges before filing.

May 9, 2023: J&J Appeals

J&J requested an interlocutory appeal to obtain an appellate court’s assessment of the preemption order before case progression, a move that may slow down proceedings.

May 1, 2023: FDA Opinion Sought

Judge Cote asked the FDA if a warning about autism and ADHD risks should be added to acetaminophen labels, an unusual move that may influence the case’s outcome.

April 21, 2023: Preemption Motion Denied

J&J’s motion to dismiss based on the preemption doctrine was rejected.

The doctrine failed to exempt J&J from potential liability regarding the lack of warning about the risks of in-utero exposure.

April 20, 2023: Government Opinion Requested

A federal judge requested the government’s perspective on whether a risk warning proposed by the plaintiffs should be added to acetaminophen labels.

April 13, 2023: Proposed Warning

The plaintiffs suggested a warning label highlighting the potential risk of autism and ADHD from frequent use of acetaminophen during pregnancy.

April 9, 2023: Rising Autism Rates

CDC data indicates that autism rates among children in the U.S. have been increasing, with recent figures showing that 1 out of every 36 children are diagnosed with autism or ASD.

March 31, 2023: Update on Expert Testimony Discovery

The MDL judge ordered rebuttal expert testimony in the expert discovery schedule in the acetaminophen-ASD-ADHD lawsuit.

The plaintiffs are now obligated to reveal, by April 4, whether they plan to provide an affirmative expert report on maternal-fetal medicine by June 16.

This fast-paced MDL class action exemplifies the necessity of rebuttal testimony, a common practice the plaintiffs intend to exercise despite the defendant’s objections.

March 27, 2023: Implementation of Plaintiff Fact Sheet

Judge Cote endorsed a comprehensive 35-page Plaintiff Fact Sheet (PFS) for all plaintiffs in the Tylenol autism class action MDL.

Like interrogatories, the PFS gathers extensive information about the plaintiffs, focusing mainly on their genetic and medical history to identify any pre-existing risk factors for autism or ADHD.

March 10, 2023: Increase in Case Numbers

The acetaminophen ADHD/autism class action litigation has grown from 80 to 107 pending cases since the initiation of the MDL a few months ago.

March 9, 2023: Plaintiffs Oppose Motion to Dismiss

In a repeated turn of events, the plaintiffs contested J&J’s Motion to Dismiss based on the federal preemption doctrine.

Despite J&J’s argument that Tylenol’s FDA-regulated warning labels are governed by federal law, Judge Cote had previously dismissed a similar motion from Walmart.

February 25, 2023: Accelerated Legal Proceedings

MDL Judge Denise Conte is promptly finalizing logistical matters in the early stages of the Tylenol autism class action.

Her recent order established protocol and timelines for expert witness depositions and fact discovery, crucial for the upcoming October ruling on the admissibility of the plaintiff’s causation evidence.

February 11, 2023: Submission of Plaintiff Fact Sheets

By February 28, 2023, parties were to submit joint or competing plaintiffs’ fact sheets outlining plaintiff information such as name, injury, defendants, and legal theories.

The collected data will be crucial for identifying common issues, providing a litigation overview, and selecting the first lawsuits to proceed to trial, known as “bellwether trials.”

February 3, 2023: Litigation Expansion

The number of Tylenol autism lawsuits within the federal MDL continues to rise.

Judge Cote recently established a process for coordinated discovery between federal and state court cases, particularly those in California.

This order enables state court cases to access discovery obtained in the federal MDL, promoting cooperation and transparency.

October 2022 Tylenol Class Action Lawsuit Update

Over the past six months, a dramatic rise in Tylenol autism-ADHD product liability claims have been observed nationwide.

Several plaintiffs filed a motion in June 2022 asking the Judicial Panel on JPML to combine all the Tylenol class action lawsuit cases in district court consolidated into a new MDL class action because there were enough active Tylenol autism cases.

The JPML registered a Tylenol autism class action lawsuit in the Southern District of New York on October 5, 2022, which will house all Tylenol lawsuits filed in any federal court in the United States.

Class Action St. Louis Tylenol Lawsuit Litigation

The JPML convened a hearing in St. Louis for oral arguments on whether to combine the expanding number of Tylenol lawsuits into a new class action lawsuit.

It started the acetaminophen lawsuit class action immediately. Many of these Tylenol autism lawsuits, alleging that taking Tylenol while pregnant caused autism, are still pending in federal courts around the US.

The Tylenol lawsuit has the potential to grow to be the most significant combined case in the nation.

MDL Motion

Several plaintiffs submitted a motion for MDL Tylenol autism lawsuits consolidated in one federal court. However, all the defendants (Tylenol drug manufacturers and distributors) opposed forming a new Tylenol class action lawsuit MDL.

The defending Tylenol lawsuit legal team might contend that an MDL cannot be initiated without the participation of the significant defendants, as it is not permitted, as noted by the MDL Tylenol lawsuit panel.

But why hasn’t Tylenol yet been identified as a defendant in an MDL civil lawsuit? Johnson & Johnson (J&J) has not been listed as a defendant in any claims that attorneys attempt to combine into a class action Tylenol lawsuit for tactical reasons.

Although there is little doubt that J&J will eventually be involved in the Tylenol class action lawsuit, it is just a question of time.

Tylenol Autism MDL Judge Does Not Dismiss Acetaminophen Lawsuits

In November 2022, a Tylenol autism MDL Judge Cote denied a motion to dismiss plaintiffs’ Tylenol autism lawsuits. Walmart sells Tylenol, and generic acetaminophen products, including in-house, Equate brand acetaminophen products.

Walmart Equate/Tylenol lawyers argued the doctrine of federal preemption barred victims’ claims. The defendant’s attorneys asked the Eastern District of New York MDL judge to reconsider the Tylenol autism litigation ruling.

On November 15, 2022, the Tylenol autism MDL judge overseeing the Tylenol autism class action lawsuit denied Walmart’s motion to dismiss the case on preemption grounds.

According to Judge Denise Cote’s order, applicable FDA labeling laws under federal law allowed Walmart to unilaterally change the label on its Equate-brand acetaminophen and add a warning about potential pregnancy risks.

Walmart to Stay in MDL

Walmart’s argued in a motion to dismiss that the applicable FDA labeling laws under federal law and regulations prohibited it from changing labels on generic Tylenol products. However, the Tylenol autism MDL judge found that it was not a valid reason for dismissal.

The denied motion to dismiss means that Walmart will remain in the class action lawsuit, further strengthening the plaintiffs’ case.

The case has raised important questions about how drug manufacturers should handle warnings about their products and if there is a link between certain drugs and conditions such as autism.

While it remains unclear what outcome the case will ultimately have, it is clear that the issue has been thrust into the spotlight and will remain a topic of conversation for some time.

Parents are advised to always consult their healthcare provider before taking any medications while pregnant or caring for an infant.